| Prostate cancer in a transgenic mouse. NM Greenberg, F DeMayo, MJ Finegold, D Medina, WD Tilley, ... Proceedings of the National Academy of Sciences 92 (8), 3439-3443, 1995 | 1617 | 1995 |
| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ... Nature genetics 50 (7), 928-936, 2018 | 768 | 2018 |
| Progesterone receptor modulates ERα action in breast cancer H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, ... Nature 523 (7560), 313-317, 2015 | 729 | 2015 |
| Characterization and expression of a cDNA encoding the human androgen receptor. WD Tilley, M Marcelli, JD Wilson, MJ McPhaul Proceedings of the National Academy of Sciences 86 (1), 327-331, 1989 | 611 | 1989 |
| Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. WD Tilley, G Buchanan, TE Hickey, JM Bentel Clinical cancer research: an official journal of the American Association …, 1996 | 547 | 1996 |
| Dual roles of PARP-1 promote cancer growth and progression MJ Schiewer, JF Goodwin, S Han, JC Brenner, MA Augello, JL Dean, ... Cancer discovery 2 (12), 1134-1149, 2012 | 461 | 2012 |
| Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer AA Peters, G Buchanan, C Ricciardelli, T Bianco-Miotto, MM Centenera, ... Cancer research 69 (15), 6131-6140, 2009 | 455 | 2009 |
| Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? TE Hickey, JLL Robinson, JS Carroll, WD Tilley Molecular endocrinology 26 (8), 1252-1267, 2012 | 328 | 2012 |
| Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1 JLL Robinson, S MacArthur, CS Ross‐Innes, WD Tilley, DE Neal, IG Mills, ... The EMBO journal 30 (15), 3019-3027, 2011 | 324 | 2011 |
| Androgens induce divergent proliferative responses in human breast cancer cell lines SN Birrell, JM Bentel, TE Hickey, C Ricciardelli, MA Weger, DJ Horsfall, ... The Journal of steroid biochemistry and molecular biology 52 (5), 459-467, 1995 | 319 | 1995 |
| Breast and prostate cancer: more similar than different GP Risbridger, ID Davis, SN Birrell, WD Tilley Nature Reviews Cancer 10 (3), 205-212, 2010 | 314 | 2010 |
| Androgen receptor coregulators and their involvement in the development and progression of prostate cancer R Chmelar, G Buchanan, EF Need, W Tilley, NM Greenberg International Journal of cancer 120 (4), 719-733, 2007 | 311 | 2007 |
| Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer HI Scher, G Buchanan, W Gerald, LM Butler, WD Tilley Endocrine-related cancer 11 (3), 459-476, 2004 | 311 | 2004 |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ... Nature genetics 53 (1), 65-75, 2021 | 305 | 2021 |
| Androgen receptor gene expression in human prostate carcinoma cell lines WD Tilley, CM Wilson, M Marcelli, MJ McPhaul Cancer Research 50 (17), 5382-5386, 1990 | 281 | 1990 |
| Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia MW Jackson, JM Bentel, WD Tilley The Journal of urology 157 (6), 2323-2328, 1997 | 278 | 1997 |
| A potential autocrine role for vascular endothelial growth factor in prostate cancer MW Jackson, JS Roberts, SE Heckford, C Ricciardelli, J Stahl, DJ Horsfall, ... Cancer research 62 (3), 854-859, 2002 | 270 | 2002 |
| Collocation of androgen receptor gene mutations in prostate cancer G Buchanan, NM Greenberg, HI Scher, JM Harris, VR Marshall, WD Tilley Clinical cancer research 7 (5), 1273-1281, 2001 | 266 | 2001 |
| Structural and functional consequences of glutamine tract variation in the androgen receptor G Buchanan, M Yang, A Cheong, JM Harris, RA Irvine, PF Lambert, ... Human molecular genetics 13 (16), 1677-1692, 2004 | 257 | 2004 |
| Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors JL Dean, AK McClendon, TE Hickey, LM Butler, WD Tilley, AK Witkiewicz, ... Cell cycle 11 (14), 2756-2761, 2012 | 245 | 2012 |
Lisa ButlerUniversity of AdelaideVerified email at adelaide.edu.au
